Search by Drug Name or NDC

    NDC 00093-5057-05 Atorvastatin Calcium 80 mg/1 Details

    Atorvastatin Calcium 80 mg/1

    Atorvastatin Calcium is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Teva Pharmaceuticals USA, Inc.. The primary component is ATORVASTATIN CALCIUM TRIHYDRATE.

    Product Information

    NDC 00093-5057
    Product ID 0093-5057_52022cc0-0b9a-4afe-91b9-283b09c2a9ed
    Associated GPIs 39400010100350
    GCN Sequence Number 045772
    GCN Sequence Number Description atorvastatin calcium TABLET 80 MG ORAL
    HIC3 M4D
    HIC3 Description ANTIHYPERLIPIDEMIC-HMGCOA REDUCTASE INHIB(STATINS)
    GCN 43723
    HICL Sequence Number 012404
    HICL Sequence Number Description ATORVASTATIN CALCIUM
    Brand/Generic Generic
    Proprietary Name Atorvastatin Calcium
    Proprietary Name Suffix n/a
    Non-Proprietary Name Atorvastatin Calcium
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 80
    Active Ingredient Units mg/1
    Substance Name ATORVASTATIN CALCIUM TRIHYDRATE
    Labeler Name Teva Pharmaceuticals USA, Inc.
    Pharmaceutical Class HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA205300
    Listing Certified Through 2024-12-31

    Package

    NDC 00093-5057-05 (00093505705)

    NDC Package Code 0093-5057-05
    Billing NDC 00093505705
    Package 500 TABLET, FILM COATED in 1 BOTTLE (0093-5057-05)
    Marketing Start Date 2022-05-23
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.07898
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description ATORVASTATIN 80 MG TABLET
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis